[1]
Tamrakar, R. and Tamrakar, D. 2022. Virologic Response Following a Switch to Dolutegravir-based Regimen in People Living with HIV/AIDS at a Tertiary Care Center in Nepal. Kathmandu University Medical Journal. 20, 4 (Dec. 2022), 438–442. DOI:https://doi.org/10.3126/kumj.v20i4.54081.